Le Lézard
Classified in: Health, Science and technology, Business
Subject: TNM

Cognosante Acquires J.Lodge, an Innovator in Contact Center Quality Assurance


FALLS CHURCH, Va., Oct. 11, 2018 /PRNewswire-PRWeb/ -- Cognosante, a leader in health information technology solutions and services, today announced the acquisition of J.Lodge, an industry leader in contact center monitoring and quality assurance.

Inspired by Jackie Lodge's personal story?a lifelong survivor of a debilitating medical condition?J. Lodge supports alternative work environments and flexible schedules, providing remote job opportunities to an under-employed segment of the U.S. population. Cognosante's acquisition of J.Lodge will expand meaningful career opportunities for disabled persons, Veterans, caregivers, and the spouses of servicemembers.

J.Lodge employs innovative technology and an exceptional U.S.-based workforce, combining practical experience with modern data science methods. J.Lodge uses proprietary MyQuality software and industry-leading speech analytics to deliver metrics-driven solutions that identify business improvement opportunities and measure tangible results. This acquisition allows Cognosante to offer differentiated quality monitoring services to its health-focused clients.

"We are extremely excited about joining forces with the right partner that shares the same vision and passion. This is an exciting time for us as we prepare to accelerate and grow our employee and customer bases," said Mike Schrider, who cofounded J.Lodge with Kolleen Schrider.

"My entrepreneurial goal has long been to maintain the dual mission of doing exceptional work for our customers and doing good for society. J.Lodge is that kind of company, and it is why I am so excited to build upon the foundation Mike and Kolleen have built," said Michele Kang, founder and CEO of Cognosante.

Reflecting its mission-focused legacy, J.Lodge will maintain its name and will operate as a wholly-owned subsidiary of Cognosante. J.Lodge senior executives will continue to support the company as Cognosante employees.

About Cognosante
Cognosante provides technology solutions, business process outsourcing, and consulting services to Federal, state, and local government health agencies. The company has nearly three decades of experience working with 48 states and the Federal government, developing, managing, and executing large, complex health information programs. Its expertise includes Medicaid; Medicare; military and Veterans' health; the health insurance marketplace; data standards and analytics; modular system development and integration; and fraud, waste, and abuse detection and prevention. Visit cognosante.com for more information.

About J.Lodge
J.Lodge, a Cognosante company, provides superior quality monitoring services and solutions for contact centers that improve customer experience and their bottom line. The company pairs the latest in speech analytics technology with top-of-the-line call, email, and chat monitoring. J.Lodge is mission-driven, and provides meaningful career opportunities for Veterans, people with disabilities, and their caregivers. Visit jlodge.com for more information.

Media Contact
Lisa Amore for J.Lodge/Cognosante
[email protected]
206.954.8006
https://twitter.com/jlodge
https://www.facebook.com/jlodgecorp/
https://www.linkedin.com/company/j.lodge/

 

SOURCE Cognosante LLC


These press releases may also interest you

at 22:00
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...



News published on and distributed by: